Security Snapshot

PROCEPT BioRobotics Corp - Common Stock (PRCT) Institutional Ownership

CUSIP: 74276L105

13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

254

Shares (Excl. Options)

55,800,271

Price

$25.01

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-302,885
Value change
-$52,002,964
Number of holders
254
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
56,408,600
SEC-reported price per share
$28.69
Insider filing price
$28.69
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PRCT - PROCEPT BioRobotics Corp - Common Stock is tracked under CUSIP 74276L105.
  • 254 institutions reported positions in Q1 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 260 to 254 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,767,134,934 to $1,396,702,755.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 254 institutions filings for Q1 2026.

Open SEC evidence

Security key

74276L105

Latest holder period

Q1 2026

13F holders

254

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
PRCT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 5.9% $100,039,657 3,271,408 T. Rowe Price Investment Management, Inc. 31 Dec 2025
BNP Paribas Asset Management Holding S.A. 5.5% $94,634,366 3,094,649 BNP Paribas Asset Management Holding S.A. 31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC 5% $70,538,954 2,820,430 Vanguard Capital Management 31 Mar 2026
FMR LLC 2.9% -68% $45,888,947 -$86,724,702 1,610,138 -65% FMR LLC 27 Feb 2026
ALLIANCEBERNSTEIN L.P. 0.3% -97% $3,392,941 -$75,364,685 147,327 -96% AllianceBernstein L.P. 31 Mar 2026

As of 31 Mar 2026, 254 institutional investors reported holding 55,800,271 shares of PROCEPT BioRobotics Corp - Common Stock (PRCT). This represents 99% of the company’s total 56,408,600 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
68%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.7% 4,362,002 +0.34% 0% $109,093,671
T. Rowe Price Investment Management, Inc. 5.8% 3,273,794 +0.07% 0.06% $81,878,000
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 5.5% 3,089,378 -0.17% 0.09% $77,265,344
VANGUARD PORTFOLIO MANAGEMENT LLC 4.3% 2,421,362 0% 0% $60,558,264
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 2,399,067 0% 0% $60,000,666
Chicago Capital, LLC 3.8% 2,160,587 +81% 1.5% $54,036,268
Prosight Management, LP 3.4% 1,945,000 +41% 8% $48,644,450
MACKENZIE FINANCIAL CORP 3.1% 1,720,738 +9.4% 0.05% $43,035,657
STATE STREET CORP 2.7% 1,529,631 +2.7% 0% $38,256,071
FMR LLC 2.6% 1,461,904 -69% 0% $36,562,211
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,363,500 +2.6% 0% $34,107,709
Artisan Partners Limited Partnership 2.1% 1,187,349 -22% 0.05% $29,695,598
Champlain Investment Partners, LLC 2% 1,136,322 -21% 0.36% $28,419,413
Point72 Asset Management, L.P. 2% 1,128,543 0.05% $28,224,860
MILLENNIUM MANAGEMENT LLC 1.8% 1,005,458 +162% 0.02% $25,146,505
MORGAN STANLEY 1.7% 977,407 +16% 0% $24,444,948
BAILLIE GIFFORD & CO 1.7% 973,502 -4.2% 0.02% $24,347,285
Fiera Capital Corp 1.7% 967,595 +250% 0.08% $24,199,551
Divisadero Street Capital Management, LP 1.5% 866,338 1% $21,667,113
WELLINGTON MANAGEMENT GROUP LLP 1.5% 861,605 0% $21,548,741
MIROVA 1.3% 723,842 0.74% $18,103,288
MARSHALL WACE, LLP 1.2% 698,232 +221% 0.02% $17,462,782
BANK OF AMERICA CORP /DE/ 1.1% 630,689 +46% 0% $15,773,532
FRONTIER CAPITAL MANAGEMENT CO LLC 1.1% 609,857 +160% 0.16% $15,252,524
PRICE T ROWE ASSOCIATES INC /MD/ 1.1% 605,958 -14% 0% $15,156,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
19
Latest
Q1 2026
Rows shown
1-19 of 19
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 55,800,271 $1,396,702,755 -$52,002,964 $25.01 254
2025 Q4 56,172,740 $1,767,134,934 -$33,699,870 $31.46 260
2025 Q3 57,841,334 $2,064,355,728 +$58,548,802 $35.69 240
2025 Q2 53,324,298 $3,071,191,009 +$166,390,640 $57.60 268
2025 Q1 50,441,243 $2,938,766,560 -$31,409,190 $58.26 277
2024 Q4 50,343,754 $4,055,248,024 +$360,452,580 $80.52 279
2024 Q3 45,709,508 $3,653,668,263 +$135,461,273 $80.12 247
2024 Q2 43,960,206 $2,685,525,179 -$132,419,664 $61.09 199
2024 Q1 45,557,093 $2,251,459,753 +$4,603,354 $49.42 161
2023 Q4 45,620,767 $1,912,068,256 +$51,914,421 $41.91 144
2023 Q3 44,490,169 $1,459,568,563 +$274,904,884 $32.81 126
2023 Q2 35,958,665 $1,271,025,645 +$114,407,722 $35.35 117
2023 Q1 32,981,587 $936,651,489 -$8,052,530 $28.40 111
2022 Q4 32,804,052 $1,362,629,543 -$35,665,010 $41.54 112
2022 Q3 33,681,921 $1,396,307,426 -$142,581,938 $41.46 100
2022 Q2 34,861,572 $1,139,650,723 +$126,543,346 $32.69 92
2022 Q1 30,975,874 $1,083,745,329 +$68,880,476 $34.99 58
2021 Q4 29,451,521 $732,329,128 +$46,766,132 $25.01 60
2021 Q3 27,226,333 $1,027,223,763 +$988,368,763 $38.15 57
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .